Grupo Allmed
- Company typePrivate
- Founded2019
- HeadquartersCaracas, Venezuela
- Headcount11–50
- GTM typeB2B
- OfferingServices
Grupo Allmed firmographics
Firmographics- Name
- Grupo Allmed
- Legal name
- Grupo Allmed
- Website
- https://grupoallmed.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Grupo Allmed industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG)
- akta.pro secondary industries
- Vaccine Ordering, Inventory Management & Cold-Chain Logistics (HLAJAHAF), Vaccines & Public Health Product Distribution (CRAOAHAI)
Keywords
Where Grupo Allmed is headquartered
LocationHeadquarters
- HQ city
- Caracas
- HQ country
- Venezuela
- HQ region
- Latin America
Offices1 record
Markets served
Grupo Allmed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Product Sales: Sale of pharmaceutical products including vaccines, medical equipment, biologicals, and immunization solutions to healthcare professionals and institutions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Grupo Allmed product offering
Product offeringCore offering
Grupo Allmed imports and distributes a portfolio of pharmaceutical products to the Venezuelan healthcare sector, including vaccines for all ages, immunization solutions, cutting-edge medical equipment, and biological products handled under specialized transport and cold-chain conditions. The company complements its distribution business with a pharmacovigilance reporting service that lets customers report adverse events and helps ensure product safety, efficacy, and quality.
Product overview
Grupo Allmed is a pharmaceutical solutions provider offering an integrated portfolio of products and services in the Venezuelan market. The company operates five core offerings: Vacunas (vaccines for all ages), Inmunización (immunization solutions), Equipos (medical technology equipment), Biológicos (specialized biological product handling), and Farmacovigilancia (pharmacovigilance reporting). These products work together to deliver comprehensive pharmaceutical solutions with quality, innovation, and commitment to healthcare.
Differentiator
Problem solved
Functional benefit
Companies that use Grupo Allmed
Customer profileSegments2 records
Ideal customer profiles2 records
Grupo Allmed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Grupo Allmed partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Grupo Allmed competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: U.S.-based global pharmaceutical and medical-product distributor serving hospitals, pharmacies, and clinical customers. Comparable for its end-to-end pharma and medical-equipment distribution capabilities and established cold-chain logistics, representing the type of global player Grupo Allmed could partner with or compete against.
- Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distribution and related-services companies, supplying pharmacies, physicians, and healthcare systems worldwide. Comparable for its full-line pharma distribution model and global reach, representing the upper bound of scale that small regional distributors operate against.
- McKesson Corporation: Global leader in pharmaceutical wholesale distribution and biopharma services, supplying retail pharmacies, hospitals, and government health systems worldwide. Comparable as a broad incumbent with established cold-chain and pharmacovigilance infrastructure that smaller LATAM distributors must compete against for multinational supplier contracts.
Regional players
- Droguería del Sud: Argentine pharmaceutical distributor serving pharmacies, hospitals, and healthcare institutions across the Southern Cone. Comparable as a regional pharma wholesaler in a similarly volatile LATAM economy, offering a benchmark for how mid-sized distributors scale cold-chain and institutional services.
- Casa Saba: Mexican pharmaceutical distribution group serving retail pharmacies, hospitals, and government programs across Mexico and Latin America. Comparable for its broad pharma distribution model and institutional-customer focus in the same LATAM region.
- Grupo Pisa: One of the largest pharmaceutical distributors in Mexico and Latin America, supplying hospitals, pharmacies, and government health programs. Comparable as a regional pharma distributor with similar institutional and immunization-product exposure across LATAM.
Others
- Sanofi Pasteur: Global vaccines business of Sanofi, one of the world's largest vaccine manufacturers. Comparable not as a competitor but as a likely upstream supplier; Grupo Allmed's ability to secure and manage Sanofi (and similar) vaccine SKUs is a key indicator of its strategic positioning in Venezuela.
Direct peers
- Corporación Drokasa: Major Venezuelan pharmaceutical wholesaler and distributor serving healthcare institutions and pharmacies. Directly comparable as a domestic pharma distributor operating in the same market with overlapping customer segments (hospitals, clinics, pharmacies).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Grupo Allmed social profiles
Digital presenceGrupo Allmed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Grupo Allmed leadership team
Management profileNumber of profiles
Profiles1 record
Grupo Allmed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Grupo Allmed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Grupo Allmed
What does Grupo Allmed do?
Grupo Allmed imports and distributes a portfolio of pharmaceutical products to the Venezuelan healthcare sector, including vaccines for all ages, immunization solutions, cutting-edge medical equipment, and biological products handled under specialized transport and cold-chain conditions. The company complements its distribution business with a pharmacovigilance reporting service that lets customers report adverse events and helps ensure product safety, efficacy, and quality.
Is Grupo Allmed a public or private company?
Grupo Allmed is a private company. It is classified as unknown and is currently operating.
When was Grupo Allmed founded?
Grupo Allmed was founded in 2019. It employs 11 to 50 people.
Where is Grupo Allmed based?
Grupo Allmed is headquartered in Caracas, Venezuela, in the Latin America region.
How does Grupo Allmed make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Grupo Allmed's main competitors?
Broad incumbents on record are Cardinal Health, Cencora (formerly AmerisourceBergen) and McKesson Corporation. Regional players are Droguería del Sud, Casa Saba and Grupo Pisa. Sanofi Pasteur is listed as an others. Corporación Drokasa is listed as a direct peer.
Does Grupo Allmed have an API?
No public API is recorded for Grupo Allmed.
What industry is Grupo Allmed in?
Grupo Allmed's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAG, Vaccines & Cold-Chain Pharmaceutical Distributors, with a secondary code of HLAJAHAF, Vaccine Ordering, Inventory Management & Cold-Chain Logistics. Its NAICS code is 424210 and its SIC code is 5122.